Here are some highlights of recently announced trials in OrthoBio that were picked up by our analysts, posted on SmartTRAK, and included in our Daily Updates email.A 76-pt study is underway evaluating if pts who receive a bioinductive graft (REGENETEN) have better function and fewer re-tear at 1-yr post-op vs those who received a debridement alone. Anticipated completion date is 9/23. clinicaltrials.gov
A 30-pt double blind, randomized, split mouth study was initiated evaluating the non-inferiority of Fibro-Gide in comparison to connective tissue graft for the tx of Miller Class I or II recession defects at 6 mos post tx. clinicaltrials.gov
ROSM and EmCyte have initiated an 84-pt study assessing if LP-PRP (PurePRP) to both the IA space and EA supporting capsular ligament and tendon structures provides a significant clinical benefit vs IA tx alone for hip OA. Expected completion date is 12/1/21. clinicaltrials.gov
Investigators have completed an 81-pt study evaluating NOVOCART 3D in adult and adolescent pts w/ full-thickness cartilage defects of the knee. No study results posted. clinicaltrials.gov
BONESUPPORT is initiating a 300-pt registry to compile data on the performance of CERAMENT BVF in normal orthopedic use. Estimated completion date is 2/1/22. clinicaltrials.gov
